elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37462477-D1EEB263-466A-4987-B08F-7A53C0649929
Q37462477-D1EEB263-466A-4987-B08F-7A53C0649929
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37462477-D1EEB263-466A-4987-B08F-7A53C0649929
Pharmacologic study (JP28927) of alectinib in Japanese patients with ALK+ non-small-cell lung cancer with or without prior crizotinib therapy.
P2860
Q37462477-D1EEB263-466A-4987-B08F-7A53C0649929
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37462477-D1EEB263-466A-4987-B08F-7A53C0649929
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ed734269942fa70c853519e01de563f4529b86af
P2860
Prevalence and natural history of ALK positive non-small-cell lung cancer and the clinical impact of targeted therapy with ALK inhibitors